Allosteric modulation of neuronal nicotinic acetylcholine receptors

Journal of Physiology Paris

Volumn 92, Issue 2, 1998, Pages 89-100

  Buisson, Bruno ^a   Bertrand, Daniel ^a  

^a Medical Faculty   (Switzerland)

Author keywords

Allosteric concepts; Nicotinic acetylcholine receptors; Site directed mutagenesis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACETYLCHOLINE; ALPHA BUNGAROTOXIN; BENZODIAZEPINE; CALCITONIN GENE RELATED PEPTIDE; ESTRADIOL; GLYCINE RECEPTOR; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; SEROTONIN RECEPTOR; STEROID; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLOSTERISM; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; CHANNEL GATING; CHOLINERGIC SYSTEM; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; LIGAND BINDING; NONHUMAN; PLEIOTROPY; PROTEIN CONFORMATION; PROTEIN MODIFICATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS;

EID: 0032464957     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80144-7     Document Type: Conference Paper

References (123)

1. [1] Ascher P., Large W.A., Rang H.P., Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells, J. Physiol. (Lond.) 295 (1979) 139-170.
2. [2] Baulieu E.E., Neurosteroids: of the nervous system, by the nervous system, for the nervous system, Rec. Prog, Horm. Res. 52 (1997) 1-32.
3. [3] Bertrand D., Valera S., Bertrand S., Ballivet M., Rungger D., Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 2 (1991) 277-280.
4. [4] Bertrand D., Revah F., Galzi J.L., Hussy N., Mulle C., Bertrand S., Ballivet M., Changeux J.P., Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain, Proc. Natl. Acad. Sci. USA 89 (1992) 1261-1265.
5. [4] Bertrand D., Galzi J.L., Devillers-Thiéry A., Bertrand S., Changeux J.P., Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal α7 nicotinic receptor, Proc. Natl. Acad. Sci, USA 90 (1993) 6971-6975.
6. [5] Bertrand D., Galzi J.L., Devillers-Thiéry A., Bertrand S., Changeux J.P., Stratification of the channel domain in neurotransmitter receptors, Curr. Opin. Neurobiol. 5 (1993) 688-693.
7. [6] Bertrand D., Changeux J.R, Nicotinic receptor: An allosteric protein specialized for intercellular communication, Semin. Neurosci. 7 (1995) 75-90.
8. [7] Bertrand D., Buisson B., Krause R.M., Hu H.Y., Bertrand S., Minireview: Electrophysiology: A method to investigate the functional properties of ligand-gated channels, J. Recept. Signal. Transduct. Res. 17 (1997) 227-242.
9. [8] Bertrand S., Devillers-Thiéry A., Palma E., Buisson B., Edelstein S.J., Corringer P.J., Changeux J.P., Bertrand D., Paradoxical allosteric effects of competitive inhibitors on neuronal alpha 7 nicotinic receptor mutants, Neuroreport 8 (1997) 3591-3596.
10. [9] Buisson B., Gopalakrishnan M., Arneric S.P., Sullivan J.P., Bertrand D., Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study, J. Neurosci. 16 (1996) 7880-7891.
11. [10] Buisson B., Bertrand D., Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor, Mol. Pharmacol. 53 (1998) 555-563.
12. [11] Buisson B., Gopalakrishnan M., Bertrand D., Stable expression of human neuronal nicotinic receptors in human embryonic kidney-293 cells, in: Arneric S.P., Brioni J.D. (Eds.), Neuronal nicotinic receptors: pharmacology and therapeutic opportunities, John Wiley & Sons Inc., New York, 1998, in press.
13. [12] Burstein E.S., Spalding T.A., Brann M.R., Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins, Mol. Pharmacol. 51 (1997) 312-319.
14. [13] Cartaud A., Coutant S., Petrucci T.C., Cartaud J., Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse, J. Biol. Chem. 273 (1998) 11321-11326.
15. [14] Changeux J.P., The acetylcholine receptor: A model for allosteric membrane proteins, Biochem. Soc. Trans. 23 (1995) 195-205.
16. [15] Charpentier S., Jarvie K.R., Severynse D.M., Caron M.G., Tiberi M., Silencing of the constitutive activity of the dopamine D1 receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties, J. Biol. Chem. 271 (1996) 28071-28076.
17. [16] Clarke P.B.S., The fall and rise of neuronal alpha-bungarotoxin binding proteins, Trends Pharmacol. Sci. 13 (1992) 407-413.
18. 125I]-alpha-bungarotoxin, J. Neurosci. 5 (1985) 1307-1315.
19. [18] Coggan J.S., Paysan J., Conroy W.G., Berg D.K., Direct recording of nicotinic responses in presynaptic nerve terminals, J. Neurosci. 17 (1997) 5798-5806.
20. [19] Colledge M., Froehner S.C., Tyrosine phosphorylation of nicotinic acetylcholine receptor mediates Grb2 binding, J. Neurosci. 17 (1997) 5038-5045.
21. [20] Colquhoun D., Sakmann B., Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels, Nature 294 (1981) 464-466.
22. [21] Corringer P.J., Galzi J.L., Eisele J.L., Bertrand S., Changeux J.P., Bertrand D., Identification of a new component of the agonist binding site of the nicotinic alpha 7 homooligomeric receptor, J. Biol. Chem. 270 (1995) 11749-11752.
23. [22] Corriveau R.A., Berg D.K., Coexpression of multiple acetylcholine receptor genes in neurons: Quantification of transcripts during development, J. Neurosci. 13 (1993) 2662-2671.
24. [23] Court J., Clementi F., Distribution of nicotinic subtypes in human brain, Alzheimer Dis. Assoc. Disord. 9 (1995) 6-14.
25. [24] Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M., A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX, Neuron 5 (1990) 847-56.
26. [25] Czajkowski C., Karlin A., Structure of the nicotinic receptor acetylcholine-binding site. Identification of acidic residues in the delta subunit within 0.9 nm of the 5 alpha subunit-binding, J. Biol. Chem. 270 (1995) 3160-3164.
27. [26] Daniels D.L., Cohen A.R., Anderson J.M., Brunger A.T., Crystal structure of the hCASK PDZ domain reveals the structural basis of class II PDZ domain target recognition, Nat. Struct. Biol. 5 (1998) 317-325.
28. [27] Devillers-Thiéry A., Galzi J.L., Eiselé J.L., Bertrand S., Bertrand D., Changeux J.P., Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels, J. Membrane Biol. 136 (1993) 97-112.
29. [28] Edelstein S.J., Changeux J.P., Allosteric proteins after thirty years: The binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors, Experientia 52 (1996) 1083-1090.
30. [29] Eggerickx D., Denef J.F., Labbe O., Hayashi Y., Refetoff S., Vassart G., Parmentier M., Libert F., Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase, Biochem. J. 309 (1995) 837-43.
31. [30] Eilers H., Schaeffer E., Bickler P.E., Forsayeth J.R., Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism, Mol. Pharmacol. 52 (1997) 1105-1112.
32. [31] Eiselé J.L., Bertrand S., Galzi J.L., Devillers-Thiéry A., Changeux J.P., Bertrand D., Chimaeric nicotinic-serotoninergic receptor combines dictinct ligand binding and channel specificities, Nature 366 (1993) 479-483.
33. [32] Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., Heinemann S., Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells, Cell 79 (1994) 705-715.
34. [33] Franke C., Hatt H., Dudel J., Liquid filament switch for ultra-fast exchanges of solutions at excised patches of synaptic membrane of crayfish muscle, Neurosci. Lett. 77 (1987) 199-204.
35. [34] Fu W.M., Liu J.J., Regulation of acetylcholine release by presynaptic nicotinic receptors at developing neuromuscular synapses, Mol. Pharmacol. 51 (1997) 390-398.
36. [35] Fuhrer C., Sugiyama J.E., Taylor R.G., Hall Z.W., Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle, EMBO J. 16 (1997) 4951-4960.
37. [36] Galzi J.L., Bertrand D., Devillers T.A., Revah F., Bertrand S., Changeux J.P., Functional significance of aromatic amino acids from three peptide loops of the alpha 7 neuronal nicotinic receptor site investigated by site-directed mutagenesis. FEBS Lett. 294 (1991) 198-202.
38. [37] Galzi J.L., Bertrand S., Corringer P.J., Changeux J.P., Bertrand D., Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor, EMBO J. 15 (1996) 5824-5832.
39. [38] Galzi J.L., Changeux J.P., Neuronal nicotinic receptors: Molecular organization and regulations, Neuropharmacology 34 (1995) 563-582.
40. [39] Galzi J.L., Devillers-Thiéry A., Hussy N., Bertrand S., Changeux J.P., Bertrand D., Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic, Nature 359 (1992) 500-505.
41. [40] Galzi J.L., Edelstein S.J., Changeux J.P., The multiple phenotypes of allosteric receptor mutants, Proc. Natl. Acad. Sci. USA 93 (1996) 1853-1858.
42. [41] Galzi J.L., Revah F., Black D., Goeldner M., Hirth C., Changeux J.P., Identification of a novel amino acid α-Tyr 93 within the active site of the acetylcholine receptor by photoaffinity labeling: additional evidence for a three-loop model of the acetylcholine binding site, J. Biol. Chem. 265 (1990) 10430-10437.
43. [42] Gether U., Ballesteros J.A., Seifert R., Sanders-Bush E., Weinstein H., Kobilka B.K., Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility, J. Biol. Chem. 272 (1997) 2587-2590.
44. [43] Gopalakrishnan M., Buisson B., Tourna E., Giordano T., Campbell J.E., Hu I.C., Donnely-Roberts D., Arneric S.P., Bertrand D., Sullivan J.P., Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor, Eur. J. Pharmacol. Mol. Pharmacol. Sec. 290 (1995) 237-246.
45. [44] Gopalakrishnan M., Molinari E.J., Sullivan J.P., Regulation of human alpha 4 beta 2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways, Mol. Pharmacol. 52 (1997) 524-534.
46. [45] Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A., Hippocampal synaptic transmission enhanced by low concentrations of nicotine, Nature 383 (1996) 713-716.
47. [46] Gurantz D., Harootunian A.T., Tsien R.Y., Dionne V.E., Margiotta J.F., VIP modulates neuronal nicotinic acetylcholine receptor function by a cyclic AMP-dependent mechanism, J. Neurosci. 14 (1994) 3540-3547.
48. [47] Harrison N.L., Majewska M.D., Harrington J.W., Barker J.L., Structure-activity relationships for steroid interaction with the gamma-aminobutyric acid A receptor complex, J. Pharmacol. Exp. Ther. 241 (1987) 346-353.
49. 3H]chlorpromazine: additional evidence for the open channel conformation, Biochemistry 25 (1986) 6109-6113.
50. [49] Henderson V.W., The epidemiology of estrogen replacement therapy and Alzheimer's disease, Neurology 48 (suppl. 7) (1997) S27-S35.
51. [50] Hodgkin A.L., Huxley A.F., A quantitative description of membrane current and its application to conduction and excitation in nerve, J. Physiol. (Lond.) 117 (1952) 500-544.
52. [51] Horch H., Sargent P.B., Synaptic and extrasynaptic distribution of two distinct populations of nicotinic acetylcholine receptor clusters in the frog cardiac ganglion, J. Neurocytol. 25 (1996) 67-77.
53. [52] Horch H.L., Sargent P.B., Perisynaptic surface distribution of multiple classes of nicotinic acetylcholine receptors on neurons in the chicken ciliary ganglion, J. Neurosci. 15 (1995) 7778-7795.
54. [53] Hsu Y.N., Edwards S.C., Wecker L., Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of alpha4 subunits of neuronal nicotinic receptors, J. Neurochem. 69 (1997) 2427-2431.
55. [54] Jackson M.B., Spontaneous openings of the acetylcholine receptor channel, Proc. Natl. Acad. Sci. USA 81 (1984) 3901-3904.
56. [55] Kao P.N., Karlin A., Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues, J. Biol. Chem. 261 (1986) 8085-8088.
57. [56] Kirsch J., Betz H., Glycine-receptor activation is required for receptor clustering in spinal neurons, Nature 392 (1998) 717-720.
58. [57] Koshland D., Nemethy G., Filmer D., Comparison of experimental binding data and theoretical models in proteins containing subunits, Biochemistry 5 (1966) 365-385.
59. [58] Krause R.M., Buisson B., Bertrand S., Corringer R-J., Galzi J.L., Changeux J.P., Bertrand D., Ivermectin: a positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptors, Mol. Pharmacol. 53 (1998) 283-294.
60. [59] Kuntzweiler T.A., Anderson D.J., Campbell J.E., Manelli A., Buisson B., Bertrand D., Arneric S.P., Donnelly-Roberts D., Characterization of recombinant human α2β2 and α3β2 neuronal nicotinic acetylcholine receptors, Soc. Neurosci. Abstr. (1997) 155.1.
61. [60] Labarca C., Nowak M.W., Zhang H.Y., Tang L.X., Deshpande P., Lester H.A., Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors, Nature 376 (1995) 514-516.
62. A receptors, Cell Mol. Neurobiol. 16 (1996) 155-174.
63. [62] Le-Novère N., Changeux J.P., Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells, J. Mol. Evol. 40 (1995) 155-172.
64. [63] Lefstin J.A., Yamamoto K.R., Allosteric effects of DNA on transcriptional regulators. Nature 392 (1998) 885-888.
65. [64] Léna C., Changeux J., Mulle C., Evidence for 'preterminal' nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus, J. Neurosci. 13 (1993) 2680-2688.
66. [65] Léna C., Changeux J.P., Allosteric modulations of the nicotinic acetylcholine receptor, Trends Neurosci. 16 (1993) 181-186.
67. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus, J. Neurosci. 17 (1997) 576-585.
68. [67] Lindstrom J., Nicotinic acetylcholine receptors in health and disease, Mol. Neurobiol. 15 (1997) 193-222.
69. [68] Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M., Steroid hormone metabolites are barbiturate-like modulators of GABA receptor, Science 232 (1986) 1004-1007.
70. [69] Margiotta J.F., Pardi D., Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity, Mol. Pharmacol. 48 (1995) 63-71.
71. [70] Marshall D.L., Redfern P.H., Wonnacott S., Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats, J. Neurochem. 68 (1997) 1511-1519.
72. [71] Mayer M.L., Benveniste M., Patneau D.K., Vyklicky L., Jr., Pharmacologic properties of NMDA receptors, Ann. N.Y. Acad. Sci. 648 (1992) 194-204.
73. [72] McEwen B.S., Gonadal and adrenal steroids regulate neurochemical and structural plasticity of the hippocampus via cellular mechanisms involving NMDA receptors, Cell Mol. Neurobiol. 16 (1996) 103-116.
74. [73] McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L., Nicotine enhancement of fast synaptic excitatory synaptic transmission in CNS by presynaptic receptors, Science 269 (1995) 1692-1696.
75. [74] McGehee D.S., Role L.W., Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons, Annu. Rev. Physiol. 57 (1995) 521-546.
76. [75] McMahon L.L., Yoon K.W., Chiappinelli V.A., Electrophysiological evidence for presynaptic nicotinic receptors in the avian ventral lateral geniculate nucleus, J. Neurophysiol. 71 (1994) 826-829.
77. [76] Monod J., Wyman J., Changeux J.P., On the nature of allosteric transitions: a plausible model, J. Mol. Biol. 12 (1965) 88-118.
78. [77] Moss S.J., Mcdonald B.J., Rudhard Y, Schoepfer R., Phosphorylation of the predicted major intracellular domains of the rat and chick neuronal nicotinic acetylcholine receptor alpha 7 subunit by cAMP-dependent protein kinase, Neuropharmacology 35 (1996) 1023-1028.
79. [78] Mulle C., Benoit P., Pinset C., Roa M., Changeux J.P., Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells, Proc. Natl. Acad. Sci. USA 85 (1988) 5728-5732.
80. [79] Mulle C., Changeux J.P., A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques, J. Neurosci. 10 (1990) 169-175.
81. [80] Mulle C., Léna C., Changeux J.P., Potentiation of nicotinic receptor response by external calcium in rat central neurons, Neuron 8 (1992) 937-945.
82. [81] Numa S., Noda M., Takahashi H., Tanabe T., Toyosato M., Furutani Y., Kikyotani S., Molecular structure of the nicotinic acetylcholine receptor, Cold Spring Harb. Symp. Quant. Biol. 48 (1983) 57-69.
83. [82] Palma E., Bertrand S., Binzoni T., Bertrand D., Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine, J. Physiol. (Lond.) 491.1 (1996) 151-161.
84. [83] Pan Z.H., Zhang D., Zhang X., Lipton S.A., Agonist-induced closure of constitutively open gamma-aminobutyric acid channels with mutated M2 domains, Proc. Natl. Acad. Sci. USA 94 (1997) 6490-6495.
85. [84] Peng X., Katz M., Gerzanich V., Anand R., Lindstrom J., Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes, Mol. Pharmacol. 45 (1994) 546-554.
86. [85] Pereira E.F., Alkondon M., Reinhardt S., Maelicke A., Peng X., Lindstrom J., Whiting P., Albuquerque E.X., Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells, J. Pharmacol. Exp. Ther. 270 (1994) 768-778.
87. [86] Prezeau L., Gomeza J., Ahern S., Mary S., Galvez T., Bockaert J., Pin J.P., Changes in the carboxyJ-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity, Mol. Pharmacol. 49 (1996) 422-429.
88. [87] Puchacz E., Buisson B., Bertrand D., Lukas R.J., Functional expression of nicotinic acetylcholine receptors containing rat alpha 7 subunits in human SH-SY5Y neuroblastoma cells, FEES Lett. 354 (1994) 155-159.
89. [88] Pugh P.C., Corriveau R.A., Conroy W.G., Berg D.K., Novel subpopulation of neuronal acetylcholine receptors among those binding alpha-bungarotoxin, Mol. Pharmacol. 47 (1995) 117-725.
90. A receptors, Neuron 4 (1990) 759-765.
91. [90] Ramarao M.K., Cohen J.B., Mechanism of nicotintc acetylcholine receptor cluster formation by rapsyn, Proc. Natl. Acad. Sci. USA 95 (1998) 4007-4012.
92. [91] Revah F., Bertrand D., Galzi J.L., Devillers-Thiéry A., Mulle C., Hussy N., Bertrand S., Bailivet M., Changeux J.P., Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor, Nature 353 (1991) 846-849.
93. [92] Rodbell M., The complex regulation of receptor-coupled G-proteins, Adv. Enzyme Regul. 37 (1997) 427-435.
94. [93] Role L.W., Berg D.K., Nicotinic receptors in the development and modulation of CNS synapses, Neuron 16 (1996) 1077-1085.
95. [94] Rosenmund C., Westbrook G.L., Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10 (1993) 805-814.
96. [95] Rubin M.M., Changeux J.P., On the nature of allosteric transitions; implications of non exclusive ligand binding, J. Mol. Biol. 21 (1966) 265-274.
97. [96] Ruiz M.L., Karpen J.W., Single cyclic nucleotide-gated channels locked in different ligand-bound states, Nature 389 (1997) 389-392.
98. [97] Rupprecht R., The neuropsychopharmacological potential of neuroactive steroids, J. Psychiatr. Res. 31 (1997) 297-314.
99. [98] Scheer A., Cotecchia S., Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation, J. Recept. Signal Transduct. Res. 17 (1997) 57-73.
100. 3H acetykholine on catecholamine and serotonin axons in brain, J. Neurosci. 42 (1984) 1495-1498.
101. [100] Séguéla P., Wadiche J., Dineley M.K., Dani J.A., Patrick J.W., Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium, J. Neurosci. 13 (1993) 596-604.
102. A receptors, Trends Pharmacol. Sci. 18 (1997) 425-429.
103. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid, Nature 392 (1998) 926-930.
104. [103] Stauffer D.A., Karlin A., Electrostatic potential of the acetykholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethio-sulfonates, Biochemistry 33 (1994) 6840-6849.
105. [104] Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F., A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy, Nature Genet. 11 (1995) 201-203.
106. [105] Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., Bertrand D., An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy, Hum. Mol. Genet. 6 (1997) 943-947.
107. A alpha1beta1 receptors, J. Membr. Biol. 154 (1996) 11-21.
108. [107] Tsigelny I., Sugiyama N., Sine S.M., Taylor P., A model of the nicotinic receptor extracellular domain based on sequence identity and residue location, Biophys. J. 73 (1997) 52-66.
109. [108] Tytgat J., Hess P., Evidence for cooperative interactions in potassium channel gating, Nature 359 (1992) 420-423.
110. [109] Ullian E.M., Mcintosh J.M., Sargent P.B., Rapid synaptic transmission in the avian ciliary ganglion is mediated by two distinct classes of nicotinic receptors, J. Neurosci. 17 (1997) 7210-7219.
111. [110] Unwin N., The nicotinic acetylcholine receptor at 9 Å resolution, J. Mol. Biol. 229 (1993) 1101-1124.
112. [111] Unwin N., Acetylcholine receptor channel imaged in the open state, Nature 373 (1995) 37-43.
113. [112] Valera S., Ballivet M., Bertrand D., Progesterone modulates a neuronal nicotinic acetylcholine receptor, Proc, Natl. Acad. Sci. USA 89 (1992) 9949-9953.
114. [113] Vernallis A.B., Conroy W.G., Berg D.K., Neurons assemble acetylcholine receptors with as many as three kinds of subunits and can segregate subunits among receptor subtypes. Neuron 10 (1993) 451-464.
115. [114] Vernino S., Amador M., Luetje C.W., Patrick J., Dani J.A., Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors, Neuron 8 (1992) 127-134.
116. [115] Wafford K.A., Thompson S.A., Thomas D., Sikela J., Wilcox A.S., Whiting P.J., Functional characterization of human gamma-aminobutyric acid A receptors containing the alpha 4 subunit, Mol. Pharmacol. 50 (1996) 670-678.
117. [116] Wess J., G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition, FASEB J. 11 (1997) 346-354.
118. [117] Wevers A., Jeske A., Lobron C., Birtsch C., Heinemann S., Maelicke A., Schroder R., Schroder H., Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization. Brain. Res. Mol. 25 (1994) 122-128.
119. [118] Wonnacott S., Presynaptic nicotinic ACh receptors, Trends Neurosci. 20 (1997) 92-98.
120. [119] Yakel J.L., Lagrutta A., Adelaman J.P., North R.A., Single amino acid substitution affect desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes, Proc. Natl. Acad. Sci. USA 90 (1993) 5030-5033.
121. [120] Yang X.H., Criswell H.E., Breese G.R., Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons, J. Pharmacol. Exp. Ther. 276 (1996) 482-489.
122. [121] Yoshihara C.M., Hall Z.W., Increased expression of the 43-kD protein disrupts acetylcholine receptor clustering in myotubes, J. Cell. Biol. 122 (1993) 169-79.
123. [122] Zhang Z.W., Coggan J.S., Berg D.K., Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin. Neuron 17 (1996) 1231-1240.